Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis

Journal of Cellular Physiology

Volumn 233, Issue 4, 2018, Pages 3024-3036

  Safarzadeh, Elham ^a,b   Orangi, Mona ^a,b   Mohammadi, Hamed ^a,b   Babaie, Farhad ^a,b   Baradaran, Behzad ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiogenesis; Cancer; Metastasis; Myeloid derived suppressor cells (MDSCs); Tumor microenvironment

Indexed keywords

MICRORNA;

ANGIOGENESIS; ANIMAL CELL; CANCER PATIENT; CANCER PROGNOSIS; CELL ACTIVATION; CELL EXPANSION; CELL INVASION; CELL MIGRATION; HUMAN; HUMAN CELL; METASTASIS; MOUSE; MYELOID-DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; TUMOR GROWTH; TUMOR MICROENVIRONMENT; ANIMAL; DISEASE EXACERBATION; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; NEOPLASM; PATHOLOGY; VASCULARIZATION;

ANIMALS; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSION; MYELOID-DERIVED SUPPRESSOR CELLS; NEOPLASM METASTASIS; NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 85026761248     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.26075     Document Type: Review

References (146)

1. Acharyya, S., Oskarsson, T., Vanharanta, S., Malladi, S., Kim, J., Morris, P. G., Seshan, V. E. (2012). A CXCL1 paracrine network links cancer chemoresistance and metastasis. Cell, 150(1), 165-178.
2. Baniyash, M. (2016). Myeloid-derived suppressor cells as intruders and targets: Clinical implications in cancer therapy. Cancer Immunology, Immunotherapy, 65(7), 857-867.
3. Bianchi, G., Borgonovo, G., Pistoia, V., & Raffaghello, L. (2011). Immunosuppressive cells and tumour microenvironment: Focus on mesenchymal stem cells and myeloid derived suppressor cells. Histology and Histopathology, 26(7), 941.
4. Binsfeld, M., Muller, J., Lamour, V., De Veirman, K., De Raeve, H., Bellahcène, A., Caers, J. (2016). Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma. Oncotarget, 7(25), 37931.
5. Bodogai, M., Moritoh, K., Lee-Chang, C., Hollander, C. M., Sherman-Baust, C. A., Wersto, R. P., Trinchieri, G. (2015). Immunosuppressive and prometastatic functions of myeloid-derived suppressive cells rely upon education from tumor-associated B cells. Cancer Research, 75(17), 3456-3465.
6. Boelte, K. C., Gordy, L. E., Joyce, S., Thompson, M. A., Yang, L., & Lin, P. C. (2011). Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PLoS ONE, 6(4), e18534.
7. Brandau, S., Moses, K., & Lang, S. (2013). The kinship of neutrophils and granulocytic myeloid-derived suppressor cells in cancer: Cousins, siblings or twins? Seminars in Cancer Biology, 23(3), 171-182.
8. Brimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A., Johnsen, H. E., & Svane, I. (2010). Increased level of both CD4+ FOXP3+ regulatory t cells and CD14+ HLA-DR−/low myeloid-derived suppressor cells and decreased level of dendritic cells in patients with multiple myeloma. Scandinavian Journal of Immunology, 72(6), 540-547.
9. Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Ostrand-Rosenberg, S. (2016). Recommendations for myeloidderived suppressor cell nomenclature and characterization standards. Nature Communications, 6(7), 12150.
10. Bronte, V., & Zanovello, P. (2005). Regulation of immune responses by L-arginine metabolism. Nature Reviews Immunology, 5(8), 641-654.
11. Cao, Y., Slaney, C. Y., Bidwell, B. N., Parker, B. S., Johnstone, C. N., Rautela, J., Anderson, R. L. (2014). BMP4 inhibits breast cancer metastasis by blocking myeloid-derived suppressor cell activity. Cancer Research, 74(18), 5091-5102.
12. Chen, M.-F., Kuan, F.-C., Yen, T.-C., Lu, M.-S., Lin, P.-Y., Chung, Y.-H., Lee, K.-D. (2014). IL-6-stimulated CD11b+ CD14+ HLA-DR-myeloidderived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Oncotarget, 5(18), 8716-8728.
13. Chen, S., Wang, L., Fan, J., Ye, C., Dominguez, D., Zhang, Y., Zhang, B. (2015). Host miR155 promotes tumor growth through a myeloidderived suppressor cell-dependent mechanism. Cancer Research, 75(3), 519-531.
14. Chen, S., Zhang, Y., Kuzel, T. M., & Zhang, B. (2015). Regulating tumor myeloid-derived suppressor cells by microRNAs. Cancer Cell & Microenvironment, 2(1), pii: e637.
15. Chi, N., Tan, Z., Ma, K., Bao, L., & Yun, Z. (2014). Increased circulating myeloid-derived suppressor cells correlate with cancer stages, interleukin-8 and-6 in prostate cancer. International Journal of Clinical and Experimental Medicine, 7(10), 3181-3192.
16. Chun, E., Lavoie, S., Michaud, M., Gallini, C. A., Kim, J., Soucy, G., Garrett, W. S. (2015). CCL2 promotes colorectal carcinogenesis by enhancing polymorphonuclear myeloid-derived suppressor cell population and function. Cell Reports, 12(2), 244-257.
17. Condamine, T., & Gabrilovich, D. I. (2011). Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function. Trends in Immunology, 32(1), 19-25.
18. Condamine, T., Mastio, J., & Gabrilovich, D. I. (2015). Transcriptional regulation of myeloid-derived suppressor cells. Journal of Leukocyte Biology, 98(6), 913-922.
19. Condamine, T., Ramachandran, I., Youn, J.-I., & Gabrilovich, D. I. (2015). Regulation of tumor metastasis by myeloid-derived suppressor cells. Annual Review of Medicine, 66, 97-110.
20. Cui, T. X., Kryczek, I., Zhao, L., Zhao, E., Kuick, R., Roh, M. H., Thomas, D. G. (2013). Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2. Immunity, 39(3), 611-621.
21. Damuzzo, V., Pinton, L., Desantis, G., Solito, S., Marigo, I., Bronte, V., & Mandruzzato, S. (2015). Complexity and challenges in defining myeloidderived suppressor cells. Cytometry Part B: Clinical Cytometry, 88(2), 77-91.
22. De Sanctis, F., Solito, S., Ugel, S., Molon, B., Bronte, V., & Marigo, I. (2016). MDSCs in cancer: Conceiving new prognostic and therapeutic targets. Biochimica Et Biophysica Acta (BBA)-Reviews on Cancer, 1865(1), 35-48.
23. Deng, Z., Rong, Y., Teng, Y., Zhuang, X., Samykutty, A., Mu, J., Miller, D. (2016). Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis. Oncogene, 36(5), 639-651.
24. Diaz-Montero, C. M., Finke, J., & Montero, A. J. (2014). Myeloid-derived suppressor cells in cancer: Therapeutic, predictive, and prognostic implications. Seminars in Oncology, 41(2), 174-184.
25. Dolcetti, L., Peranzoni, E., Ugel, S., Marigo, I., Fernandez Gomez, A., Mesa, C., Casati, A. (2010). Hierarchy of immunosuppressive strength among myeloid-derived suppressor cell subsets is determined by GM-CSF. European Journal of Immunology, 40(1), 22-35.
26. Dumitru, C. A., Lang, S., & Brandau, S. (2013). Modulation of neutrophil granulocytes in the tumor microenvironment: Mechanisms and consequences for tumor progression. Seminars in Cancer Biology, 23(3), 141-148.
27. Dunn, G. P., Old, L. J., & Schreiber, R. D. (2004). The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 21(2), 137-148.
28. Eming, S. A., & Hubbell, J. A. (2011). Extracellular matrix in angiogenesis: Dynamic structures with translational potential. Experimental Dermatology, 20(7), 605-613.
29. Erler, J. T., Bennewith, K. L., Cox, T. R., Lang, G., Bird, D., Koong, A., Giaccia, A. J. (2009). Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Cancer Cell, 15(1), 35-44.
30. Escors, D., Talmadge, J. E., Breckpot, K., Van Ginderachter, J. A., & Kochan, G. (2016). Myeloid-derived suppressor cells and cancer. Switzerland: Springer International Publishing.
31. Eyles, J., Puaux, A.-L., Wang, X., Toh, B., Prakash, C., Hong, M., Jin, Y. (2010). Tumor cells disseminate early, but immunosurveillance limits metastatic outgrowth, in a mouse model of melanoma. The Journal of Clinical Investigation, 120(6), 2030-2039.
32. Ezernitchi, A. V., Vaknin, I., Cohen-Daniel, L., Levy, O., Manaster, E., Halabi, A., Baniyash, M. (2006). TCR ζ down-regulation under chronic inflammation is mediated by myeloid suppressor cells differentially distributed between various lymphatic organs. The Journal of Immunology, 177(7), 4763-4772.
33. Feng, P.-H., Lee, K.-Y., Chang, Y.-L., Chan, Y.-F., Kuo, L.-W., Lin, T.-Y., Lin, S.-M. (2012). CD14+ S100A9+ monocytic myeloid-derived suppressor cells and their clinical relevance in non-small cell lung cancer. American Journal of Respiratory and Critical Care Medicine, 186(10), 1025-1036.
34. Filipazzi, P., Huber, V., & Rivoltini, L. (2012). Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients. Cancer Immunology. Immunotherapy, 61(2), 255-263.
35. Folkman, J. (1971). Tumor angiogenesis: Therapeutic implications. New England Journal of Medicine, 285(21), 1182-1186.
36. Fujimura, T., Mahnke, K., & Enk, A. H. (2010). Myeloid derived suppressor cells and their role in tolerance induction in cancer. Journal of Dermatological Science, 59(1), 1-6.
37. Gabrilovich, D., Ishida, T., Oyama, T., Ran, S., Kravtsov, V., Nadaf, S., & Carbone, D. P. (1998). Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 92(11), 4150-4166.
38. Gabrilovich, D. I., & Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews Immunology, 9(3), 162-174.
39. Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012). Coordinated regulation of myeloid cells by tumours. Nature Reviews Immunology, 12(4), 253-268.
40. Gallina, G., Dolcetti, L., Serafini, P., De Santo, C., Marigo, I., Colombo, M. P., Zanovello, P. (2006). Tumors induce a subset of inflammatory monocytes with immunosuppressive activity on CD8+ T cells. The Journal of Clinical Investigation, 116(10), 2777-2790.
41. Garrity, T., Pandit, R., Wright, M. A., Benefield, J., Keni, S., & Young, M. R. I. (1997). Increased presence of CD34+ cells in the peripheral blood of head and neck cancer patients and their differentiation into dendritic cells. International Journal of Cancer, 73(5), 663-669.
42. Gehad, A. E., Lichtman, M. K., Schmults, C. D., Teague, J. E., Calarese, A. W., Jiang, Y., Clark, R. A. (2012). Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas. Journal of Investigative Dermatology, 132(11), 2642-2651.
43. Gieryng, A., & Kaminska, B. (2016). Myeloid-derived suppressor cells in gliomas. Contemporary Oncology (Poznań), 20(5), 345-351.
44. Gunaydin, G., Kesikli, S. A., & Guc, D. (2015). Cancer associated fibroblasts have phenotypic and functional characteristics similar to the fibrocytes that represent a novel MDSC subset. Oncoimmunology, 4(9), e1034918.
45. Han, S., & Yang, Y. (2016). Phenotypic and functional dissection of myeloidderived suppressor cells. Applied Biological Chemistry, 59(3), 367-371.
46. Hemmatzadeh, M., Mohammadi, H., Karimi, M., Musavishenas, M. H., & Baradaran, B. (2016). Differential role of microRNAs in the pathogenesis and treatment of Esophageal cancer. Biomedicine & Pharmacotherapy, 82, 509-519.
47. Hestdal, K., Ruscetti, F., Ihle, J., Jacobsen, S., Dubois, C., Kopp, W., Keller, J. (1991). Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. The Journal of Immunology, 147(1), 22-28.
48. Hiratsuka, S., Watanabe, A., Aburatani, H., & Maru, Y. (2006).Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nature Cell Biology, 8(12), 1369-1375.
49. Hood, J. L., San, R. S., & Wickline, S. A. (2011). Exosomes released by melanoma cells prepare sentinel lymph nodes for tumor metastasis. Cancer Research, 71(11), 3792-3801.
50. Huang, A., Zhang, B., Wang, B., Zhang, F., Fan, K.-X., & Guo, Y.-J. (2013). Increased CD14+ HLA-DR-/low myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunology, Immunotherapy, 62(9), 1439-1451.
51. Huang, A., Zhang, H., Chen, S., Xia, F., Yang, Y., Dong, F., Zhang, J. (2014). MiR-34a expands myeloid-derived suppressor cells via apoptosis inhibition. Experimental Cell Research, 326(2), 259-266.
52. Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Chen, S.-H. (2006). Gr-1+ CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. Cancer Research, 66(2), 1123-1131.
53. Ichikawa, M., Williams, R., Wang, L., Vogl, T., & Srikrishna, G. (2011). S100A8/A9 activate key genes and pathways in colon tumor progression. Molecular Cancer Research, 9(2), 133-148.
54. Inamoto, S., Itatani, Y., Yamamoto, T., Minamiguchi, S., Hirai, H., Iwamoto, M., Kawada, K. (2016). Loss of SMAD4 promotes colorectal cancer progression by accumulation of myeloid-derived suppressor cells through the CCL15-CCR1 chemokine axis. Clinical Cancer Research, 22(2), 492-501.
55. Itatani, Y., Kawada, K., Inamoto, S., Yamamoto, T., Ogawa, R., Taketo, M. M., & Sakai, Y. (2016). The role of chemokines in promoting colorectal cancer invasion/metastasis. International Journal of Molecular Sciences, 17(5), 643.
56. Jiang, J., Guo, W., & Liang, X. (2014). Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients. Human Immunology, 75(11), 1128-1137.
57. Joyce, J. A., & Pollard, J. W. (2009). Microenvironmental regulation of metastasis. Nature Reviews Cancer, 9(4), 239-252.
58. Kanterman, J., Sade-Feldman, M., & Baniyash, M. (2012). New insights into chronic inflammation-induced immunosuppression. Seminars in Cancer Biology, 22(4), 307-318.
59. Kao, J., Ko, E. C., Eisenstein, S., Sikora, A. G., Fu, S., & Chen, S.-H. (2011). Targeting immune suppressing myeloid-derived suppressor cells in oncology. Critical Reviews in Oncology/Hematology, 77(1), 12-19.
60. Katoh, H., & Watanabe, M. (2015). Myeloid-derived suppressor cells and therapeutic strategies in cancer. Mediators of Inflammation, 2015, 12.
61. Khaled, Y. S., Ammori, B. J., & Elkord, E. (2013). Myeloid-derived suppressor cells in cancer: Recent progress and prospects. Immunology and Cell Biology, 91(8), 493-502.
62. Khaled, Y. S., Ammori, B. J., & Elkord, E. (2014). Increased levels of granulocytic myeloid-derived suppressor cells in peripheral blood and tumour tissue of pancreatic cancer patients. Journal of Immunology Research, 2014, 9.
63. Kitamura, T., Qian, B.-Z., & Pollard, J. W. (2015). Immune cell promotion of metastasis. Nature Reviews Immunology, 15(2), 73-86.
64. Ko, J. S., Rayman, P., Ireland, J., Swaidani, S., Li, G., Bunting, K. D., Cohen, P. A. (2010). Direct and differential suppression of myeloid-derived suppressor cell subsets by sunitinib is compartmentally constrained. Cancer Research, 70(9), 3526-3536.
65. Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016). The nature of myeloid-derived suppressor cells in the tumor microenvironment. Trends in Immunology, 37(3), 208-220.
66. Kusmartsev, S., & Gabrilovich, D. I. (2006). Role of immature myeloid cells in mechanisms of immune evasion in cancer. Cancer Immunology, Immunotherapy, 55(3), 237-245.
67. Liu, L., Ye, T. H., Han, Y. P., Song, H., Zhang, Y. K., Xia, Y., Zhu, Y. X. (2014). Reductions in myeloid-derived suppressor cells and lung metastases using AZD4547 treatment of a metastatic murine breast tumor model. Cellular Physiology and Biochemistry, 33(3), 633-645.
68. Liu, Y., Lai, L., Chen, Q., Song, Y., Xu, S., Ma, F., Cao, X. (2012). MicroRNA-494 is required for the accumulation and functions of tumor-expanded myeloid-derived suppressor cells via targeting of PTEN. The Journal of Immunology, 188(11), 5500-5510.
69. Mandruzzato, S., Brandau, S., Britten, C. M., Bronte, V., Damuzzo, V., Gouttefangeas, C., Welters, M. J. (2016). Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: Results from an interim study. Cancer Immunology, Immunotherapy, 65(2), 161-169.
70. Mandruzzato, S., Solito, S., Falisi, E., Francescato, S., Chiarion-Sileni, V., Mocellin, S., Bronte, V. (2009). IL4Rα+ myeloid-derived suppressor cell expansion in cancer patients. The Journal of Immunology, 182(10), 6562-6568.
71. Mao, Y., Keller, E. T., Garfield, D. H., Shen, K., & Wang, J. (2013). Stromal cells in tumor microenvironment and breast cancer. Cancer and Metastasis Reviews, 32(1-2), 303-315.
72. Marvel, D., & Gabrilovich, D. I. (2015). Myeloid-derived suppressor cells in the tumor microenvironment: Expect the unexpected. The Journal of Clinical Investigation, 125(9), 3356-3364.
73. Mazza, E. M. C., Zoso, A., Mandruzzato, S., Bronte, V., Serafini, P., Inverardi, L., & Bicciato, S. (2014). Gene expression profiling of human fibrocytic myeloid-derived suppressor cells (f-MDSCs). Genomics Data, 2, 389-392.
74. Mehta, A., & Baltimore, D. (2016). MicroRNAs as regulatory elements in immune system logic. Nature Reviews Immunology, 16(5), 279-294.
75. Meirow, Y., Kanterman, J., & Baniyash, M. (2015). Paving the road to tumor development and spreading: Myeloid-derived suppressor cells are ruling the fate. Frontiers in Immunology, 12(6), 523.
76. Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Massagué, J. (2005). Genes that mediate breast cancer metastasis to lung. Nature, 436(7050), 518-524.
77. Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., Rescigno, M. (2011). Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells. Journal of Experimental Medicine, 208(10), 1949-1962.
78. Motallebnezhad, M., Jadidi-Niaragh, F., Qamsari, E. S., Bagheri, S., Gharibi, T., & Yousefi, M. (2016). The immunobiology of myeloid-derived suppressor cells in cancer. Tumor Biology, 37(2), 1387-1406.
79. Nagaraj, S., & Gabrilovich, D. I. (2008). Tumor escape mechanism governed by myeloid-derived suppressor cells. Cancer Research, 68(8), 2561-2563.
80. Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010). Mechanism of T cell tolerance induced by myeloid-derived suppressor cells. The Journal of Immunology, 184(6), 3106-3116.
81. Najjar, Y. G., & Finke, J. H. (2014). Clinical perspectives on targeting of myeloid derived suppressor cells in the treatment of cancer. Cancer Immunotherapy & Immuno-monitoring: Mechanism. Treatment, Diagnosis, and Emerging Tools, 15(3), 49.
82. O’connell, R. M., Rao, D. S., Chaudhuri, A. A., & Baltimore, D. (2010). Physiological and pathological roles for microRNAs in the immune system. Nature Reviews Immunology, 10(2), 111-122.
83. Obermajer, N., Muthuswamy, R., Lesnock, J., Edwards, R. P., & Kalinski, P. (2011). Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood, 118(20), 5498-5505.
84. Obermajer, N., Muthuswamy, R., Odunsi, K., Edwards, R. P., & Kalinski, P. (2011). PGE2-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Research, 71(24), 7463-7470.
85. Obermajer, N., Wong, J. L., Edwards, R. P., Odunsi, K., Moysich, K., & Kalinski, P. (2012). PGE2-driven induction and maintenance of cancerassociated myeloid-derived suppressor cells. Immunological Investigations, 41(6-7), 635-657.
86. Oh, K., Lee, O.-Y., Shon, S. Y., Nam, O., Ryu, P. M., Seo, M. W., & Lee, D.-S. (2013). A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model. Breast Cancer Research, 15(5), R79.
87. Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012). Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression. Seminars in Cancer Biology, 22(4), 275-281.
88. OuYang, L.-Y., Wu, X.-J., Ye, S.-B., Zhang, R.-, Li, Z.-L., Liao, W., Wang, Z. (2015). Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer. Journal of Translational Medicine, 13(1), 47.
89. Page-McCaw, A., Ewald, A. J., & Werb, Z. (2007). Matrix metalloproteinases and the regulation of tissue remodelling. Nature Reviews Molecular Cell Biology, 8(3), 221-233.
90. Pan, W., Sun, Q., Wang, Y., Wang, J., Cao, S., & Ren, X. (2015). Highlights on mechanisms of drugs targeting MDSCs: Providing a novel perspective on cancer treatment. Tumor Biology, 36(5), 3159-3169.
91. Panka, D. J., Arbeit, R. D., & Mier, J. W. (2016). Regulation of MDSC trafficking and function in RCC by CXCR4 in the presence of a VEGF-R antagonist. AACR.
92. Panni, R. Z., Sanford, D. E., Belt, B. A., Mitchem, J. B., Worley, L. A., Goetz, B. D., DeNardo, D. G. (2014). Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunology, Immunotherapy, 63(5), 513-528.
93. Parker, K. H., Beury, D. W., & Ostrand-Rosenberg, S. (2015). Chapter threemyeloid-derived suppressor cells: Critical cells driving immune suppression in the tumor microenvironment. Advances in Cancer Research, 128, 95-139.
94. Peinado, H., Lavotshkin, S., & Lyden, D. (2011). The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts. Seminars in Cancer Biology, 21(2), 139-146.
95. Pekarek, L. A., Starr, B. A., Toledano, A. Y., & Schreiber, H. (1995). Inhibition of tumor growth by elimination of granulocytes. Journal of Experimental Medicine, 181(1), 435-440.
96. Peng, D., Tanikawa, T., Li, W., Zhao, L., Vatan, L., Szeliga, W., Liu, Y. (2016). Myeloid-derived suppressor cells endow stem-like qualities to breast cancer cells through IL6/STAT3 and NO/NOTCH cross-talk signaling. Cancer Research, 76(11), 3156-3165.
97. Piva, R., Spandidos, D. A., & Gambari, R. (2013). From microRNA functions to microRNA therapeutics: Novel targets and novel drugs in breast cancer research and treatment (Review). International Journal of Oncology, 43(4), 985-994.
98. Poschke, I., & Kiessling, R. (2012). On the armament and appearances of human myeloid-derived suppressor cells. Clinical Immunology, 144(3), 250-268.
99. Qu, P., Wang, L.-Z., & Lin, P. C. (2016). Expansion and functions of myeloidderived suppressor cells in the tumor microenvironment. Cancer Letters, 380(1), 253-256.
100. Qu, X., Zhuang, G., Yu, L., Meng, G., & Ferrara, N. (2012). Induction of bv8 expression by granulocyte colony-stimulating factor in CD11b+ Gr1+ cells key role of Stat3 signaling. Journal of Biological Chemistry, 287(23), 19574-19584.
101. Quail, D. F., & Joyce, J. A. (2013). Microenvironmental regulation of tumor progression and metastasis. Nature Medicine, 19(11), 1423-1437.
102. Ribechini, E., Greifenberg, V., Sandwick, S., & Lutz, M. B. (2010). Subsets, expansion and activation of myeloid-derived suppressor cells. Medical Microbiology and Immunology, 199(3), 273-281.
103. Rodriguez, P. C., Ernstoff, M. S., Hernandez, C., Atkins, M., Zabaleta, J., Sierra, R., & Ochoa, A. C. (2009). Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Research, 69(4), 1553-1560.
104. Sasano, T., Mabuchi, S., Takahashi, R., Kuroda, H., Sawada, K., & Kimura, T. (2015). Granulocyte-colony stimulating factor (G-CSF) facilitates metastasis of uterine cervical cancer by recruiting myeloid-derived suppressor cells (MDSCs) via CXCL12-CXCR4 axis. AACR.
105. Sceneay, J., Parker, B. S., Smyth, M. J., & Möller, A. (2013). Hypoxiadriven immunosuppression contributes to the pre-metastatic niche. Oncoimmunology, 2(1), e22355.
106. Sceneay, J., Smyth, M. J., & Möller, A. (2013). The pre-metastatic niche: Finding common ground. Cancer and Metastasis Reviews, 32(3-4), 449-464.
107. Schlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V., & Cerwenka, A. (2012). Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth. The Journal of Immunology, 189(12), 5602-5611.
108. Serafini, P., Borrello, I., & Bronte, V. (2006). Myeloid suppressor cells in cancer: Recruitment, phenotype, properties, and mechanisms of immune suppression. Seminars in Cancer Biology, 16(1), 53-65.
109. Serafini, P., Carbley, R., Noonan, K. A., Tan, G., Bronte, V., & Borrello, I. (2004). High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Research, 64(17), 6337-6343.
110. Serafini, P., De Santo, C., Marigo, I., Cingarlini, S., Dolcetti, L., Gallina, G., Bronte, V. (2004). Derangement of immune responses by myeloid suppressor cells. Cancer Immunology, Immunotherapy, 53(2), 64-72.
111. Sevko, A., & Umansky, V. (2013). Myeloid-derived suppressor cells interact with tumors in terms of myelopoiesis, tumorigenesis and immunosuppression: Thick as thieves. Journal of Cancer, 4(1), 3-11.
112. Seyfizadeh, N. (2016). Immune dysfunction induced by myeloid-derived suppressor cells in lymphoma. Cancer Cell & Microenvironment, 3(1), e1111.
113. Shen, P., Wang, A., He, M., Wang, Q., & Zheng, S. (2014). Increased circulating Lin−/lowCD33+ HLA-DR− myeloid-derived suppressor cells in hepatocellular carcinoma patients. Hepatology Research, 44(6), 639-650.
114. Shojaei, F., Wu, X., Zhong, C., Yu, L., Liang, X.-H., Yao, J., Van Bruggen, N. (2007). Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature, 450(7171), 825-831.
115. Simpson, K. D., Templeton, D. J., & Cross, J. V. (2012). Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment. The Journal of Immunology, 189(12), 5533-5540.
116. Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007). Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response. The Journal of Immunology, 179(2), 977-983.
117. Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., & Srikrishna, G. (2008). Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. The Journal of Immunology, 181(7), 4666-4675.
118. Sleeman, J. P. (2012). The metastatic niche and stromal progression. Cancer and Metastasis Reviews, 31(3-4), 429-440.
119. Solheim, J., Reber, A., Ashour, A., Robinson, S., Futakuchi, M., Kurz, S., Cornell, D. (2007). Spleen but not tumor infiltration by dendritic and T cells is increased by intravenous adenovirus-Flt3 ligand injection. Cancer Gene Therapy, 14(4), 364-371.
120. Solito, S., Marigo, I., Pinton, L., Damuzzo, V., Mandruzzato, S., & Bronte, V. (2014). Myeloid-derived suppressor cell heterogeneity in human cancers. Annals of the New York Academy of Sciences, 1319(1), 47-65.
121. Sumida, K., Wakita, D., Narita, Y., Masuko, K., Terada, S., Watanabe, K., Nishimura, T. (2012). Anti-IL-6 receptor mAb eliminates myeloidderived suppressor cells and inhibits tumor growth by enhancing T-cell responses. European Journal of Immunology, 42(8), 2060-2072.
122. Talmadge, J. E. (2007). Pathways mediating the expansion and immunosuppressive activity of myeloid-derived suppressor cells and their relevance to cancer therapy. Clinical Cancer Research, 13(18), 5243-5248.
123. Talmadge, J. E., & Gabrilovich, D. I. (2013). History of myeloid-derived suppressor cells. Nature Reviews Cancer, 13(10), 739-752.
124. Tian, J., Rui, K., Tang, X., Ma, J., Wang, Y., Tian, X., Wang, S. (2015). MicroRNA-9 regulates the differentiation and function of myeloidderived suppressor cells via targeting Runx1. The Journal of Immunology, 195(3), 1301-1311.
125. Tjiu, J.-W., Chen, J.-S., Shun, C.-T., Lin, S.-J., Liao, Y.-H., Chu, C.-Y., Inoue, H. (2009). Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. Journal of Investigative Dermatology, 129(4), 1016-1025.
126. Toh, B., Wang, X., Keeble, J., Sim, W. J., Khoo, K., Wong, W.-C., Abastado, J.-P. (2011). Mesenchymal transition and dissemination of cancer cells is driven by myeloid-derived suppressor cells infiltrating the primary tumor. PLoS Biology, 9(9), e1001162.
127. Turner, M., Galloway, A., & Vigorito, E. (2014). Noncoding RNA and its associated proteins as regulatory elements of the immune system. Nature Immunology, 15(6), 484-491.
128. Ugel, S., De Sanctis, F., Mandruzzato, S., & Bronte, V. (2015). Tumorinduced myeloid deviation: When myeloid-derived suppressor cells meet tumor-associated macrophages. The Journal of Clinical Investigation, 125(9), 3365-3376.
129. Vences-Catalán, F., Rajapaksa, R., Srivastava, M. K., Marabelle, A., Kuo, C.-C., Levy, R., & Levy, S. (2015). Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells. Cancer Research, 75(21), 4517-4526.
130. Waight, J. D., Hu, Q., Miller, A., Liu, S., & Abrams, S. I. (2011). Tumor-derived G-CSF facilitates neoplastic growth through a granulocytic myeloidderived suppressor cell-dependent mechanism. PLoS ONE, 6(11), e27690.
131. Waight, J. D., Netherby, C., Hensen, M. L., Miller, A., Hu, Q., Liu, S., Liu, K. (2013). Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis. The Journal of Clinical Investigation, 123(10), 4464-4478.
132. Walter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Mendrzyk, R. (2012). Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nature Medicine, 18(8), 1254-1261.
133. Wang, L., Chang, E. W., Wong, S. C., Ong, S.-M., Chong, D. Q., & Ling, K. L. (2013). Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. The Journal of Immunology, 190(2), 794-804.
134. Wesolowski, R., Markowitz, J., & Carson, W. E. (2013). Myeloid derived suppressor cells-a new therapeutic target in the treatment of cancer. Journal for Immunotherapy of Cancer, 1(1), 10.
135. Williams, S. A., Harata-Lee, Y., Comerford, I., Anderson, R. L., Smyth, M. J., & McColl, S. R. (2010). Multiple functions of CXCL12 in a syngeneic model of breast cancer. Molecular Cancer, 9(1), 250.
136. Yan, H. H., Pickup, M., Pang, Y., Gorska, A. E., Li, Z., Chytil, A., Yang, L. (2010). Gr-1+ CD11b+ myeloid cells tip the balance of immune protection to tumor promotion in the premetastatic lung. Cancer Research, 70(15), 6139-6149.
137. Yang, L., DeBusk, L. M., Fukuda, K., Fingleton, B., Green-Jarvis, B., Shyr, Y., Lin, P. C. (2004). Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. Cancer Cell, 6(4), 409-421.
138. Yang, L., Huang, J., Ren, X., Gorska, A. E., Chytil, A., Aakre, M., Lin, P. C. (2008). Abrogation of TGFβ signaling in mammary carcinomas recruits Gr-1+ CD11b+ myeloid cells that promote metastasis. Cancer Cell, 13(1), 23-35.
139. Youn, J.-I., Collazo, M., Shalova, I. N., Biswas, S. K., & Gabrilovich, D. I. (2012). Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Journal of Leukocyte Biology, 91(1), 167-181.
140. Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008). Subsets of myeloid-derived suppressor cells in tumor-bearing mice. The Journal of Immunology, 181(8), 5791-5802.
141. Younos, I., Donkor, M., Hoke, T., Dafferner, A., Samson, H., Westphal, S., & Talmadge, J. (2011). Tumor-and organ-dependent infiltration by myeloid-derived suppressor cells. International Immunopharmacology, 11(7), 816-826.
142. Younos, I. H., Dafferner, A. J., Gulen, D., Britton, H. C., & Talmadge, J. E. (2012). Tumor regulation of myeloid-derived suppressor cell proliferation and trafficking. International Immunopharmacology, 13(3), 245-256.
143. Yu, J., Du, W., Yan, F., Wang, Y., Li, H., Cao, S., Ren, X. (2013). Myeloidderived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer. The Journal of Immunology, 190(7), 3783-3797.
144. Zea, A. H., Rodriguez, P. C., Atkins, M. B., Hernandez, C., Signoretti, S., Zabaleta, J., O’Neill, A. (2005). Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion. Cancer Research, 65(8), 3044-3048.
145. Zhao, X., Rong, L., Zhao, X., Li, X., Liu, X., Deng, J., Wu, P. (2012). TNF signaling drives myeloid-derived suppressor cell accumulation. The Journal of Clinical Investigation, 122(11), 4094-4104.
146. Zoso, A., Mazza, E., Bicciato, S., Mandruzzato, S., Bronte, V., Serafini, P., & Inverardi, L. (2014). Human fibrocytic myeloid-derived suppressor cells express IDO and promote tolerance via Treg-cell expansion. European Journal of Immunology, 44(11), 3307-3319.